Researchers at Western University’s Schulich School of Medicine & Dentistry have published a study showing the significant, long-term impacts of delta-9-tetrahydrocannabinol (THC) – the psychoactive component in marijuana – on the adolescent brain.
After adolescent rodents were exposed to THC, researchers noted substantial and persistent behavioural, neuronal and molecular changes that are identical to neuropsychiatric conditions, such as schizophrenia. In contrast, adult rodents exposed to THC in the same study did not show the same changes.
The research was conducted by Steven Laviolette, PhD, professor in the departments of Anatomy and Cell Biology, and Psychiatry, lead author Justine Renard, PhD, and a team of researchers at Schulich Medicine & Dentistry and the School’s Addiction Research Group.
Researchers identified and performed tests in areas of behaviour that are commonly observed in schizophrenia and other neuropsychiatric disorders, such as social interaction, motivation and cognition, exploratory behaviours, levels of anxiety, cognitive disorganization (the inability to filter out unnecessary information), and various neuronal and molecular changes.
Adolescent rodents with THC exposure were socially withdrawn, and had increased anxiety, cognitive disorganization and abnormal levels of dopamine – all factors present in clinical populations of schizophrenia. These changes continued into early adulthood, well past the initial exposure.
Adult rodents showed no harmful long-term effects, though both adolescents and adults exposed to THC experienced deficits in social cognition and memory.
With the common use of marijuana by teenagers and the federal government’s move toward legalizing marijuana, Laviolette sees clear implications for his research. “Adolescence is a critical period of brain development and the adolescent brain is particularly vulnerable,” said Laviolette. “Health policy makers need to ensure that marijuana, especially marijuana strains with high THC levels, stays out of the hands of teenagers. In contrast, our findings suggest that adult use of marijuana does not pose substantial risk.”
“Our research improves our knowledge of how adolescent exposure to THC may lead to the onset of schizophrenia in adulthood,” said Renard. “With the current rise in adolescent cannabis use and the increasing THC content in newer cannabis strains, it is critically important to highlight the risk factors associated with exposure to marijuana, particularly during adolescence.”
The study was published online in the January issue of Cerebral Cortex and can be accessed at http://cercor.oxfordjournals.org/content/early/2016/01/04/cercor.bhv335.full?sid=46cf7fe8-ae6a-49f9-8494-ec8ffe3e2431
MEDIA CONTACT: Tristan Joseph, Media Relations Officer, Schulich School of Medicine & Dentistry, Western University, t. 519.661.2111 ext. 80387, c. 519.777.1573, firstname.lastname@example.org
Western delivers an academic experience second to none. Since 1878, The Western Experience has combined academic excellence with life-long opportunities for intellectual, social and cultural growth in order to better serve our communities. Our research excellence expands knowledge and drives discovery with real-world application. Western attracts individuals with a broad worldview, seeking to study, influence and lead in the international community.
ABOUT THE SCHULICH SCHOOL OF MEDICINE & DENTISTRY
The Schulich School of Medicine & Dentistry at Western University is one of Canada’s preeminent medical and dental schools. Established in 1881, it was one of the founding schools of Western University and is known for being the birthplace of family medicine in Canada. For more than 130 years, the School has demonstrated a commitment to academic excellence and a passion for scientific discovery.
Follow Western Media Relations online: